14th Feb 2006 07:00
ReGen Therapeutics PLC13 February 2006 ReGen Therapeutics Plc 14 February 2006 Completion of the acquisition of Sciencom Limited ReGen Therapeutics Plc ('ReGen'), is pleased to announce that all of theconditions to the acquisition of the entire issued share capital of SciencomLimited (the 'Acquisition') have now been satisfied and that the Acquisition wascompleted earlier today. Admission of 1,562,500 new ordinary shares of ReGen to trading on the AIM marketof the London Stock Exchange, issued as consideration for the Acquisition alsotook place earlier today. For further information, please contact:Andrew MarshallGreycoat CommunicationsTel: 020 7960 6007Mobile: 07785 297111 This information is provided by RNS The company news service from the London Stock ExchangeRelated Shares:
TILS.L